Embassy developments announced the approval of fresh stock option grants to its employees under the Embassy Developments Limited Employee Stock Option Scheme 2025. The company's Nomination and Remuneration Committee made these decisions during its meeting held on February 9, 2025, as part of its ongoing employee incentive program.

Grant Details and Lapsed Options

The committee approved the grant of 9,15,265 Stock Options and 7,25,301 Performance Stock Units to eligible employees. Simultaneously, the committee noted the lapse of 2,84,924 Stock Options and 37,52,477 Performance Stock Units, which have been added back to the total pool in accordance with the Embassy ESOS 2025 provisions.

Scheme Structure and Compliance

The Embassy ESOS 2025 has been formulated in compliance with SEBI SBE & SE Regulations, 2021, following shareholder approval and receipt of necessary in-principle approvals from both the National Stock Exchange of India Limited and BSE Limited. Each Stock Option is convertible into one equity share of face value INR 2.00 each, while each Performance Stock Unit converts into equity shares based on achievement of performance parameters.

Vesting and Exercise Terms

The Stock Options granted will vest uniformly over 4 years with a 25% vesting schedule at the end of each year from the grant date. Performance Stock Units will vest upon meeting respective milestones anytime between year 3 and 4, with vesting percentages and equity share numbers dependent on achievement against targets as per Embassy ESOS 2025.

Regulatory Disclosure

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided comprehensive details as required under the SEBI Master Circular dated January 30, 2026, ensuring full regulatory compliance for the stock option grants.

Embassy Developments Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing significant losses across both standalone and consolidated operations. The Board of Directors approved these results at their meeting held on February 09, 2026, pursuant to Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations.

Standalone Financial Performance

The company's standalone operations showed a marked deterioration in Q3FY26 performance compared to the previous year:

The company reported a standalone loss of Rs 739.63 millions for Q3FY26, a significant decline from the profit of Rs 28.97 millions recorded in the corresponding quarter of the previous year. Revenue from operations dropped dramatically by 86.3% to Rs 405.22 millions from Rs 2,948.33 millions in Q3FY25.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, the standalone results showed:

The nine-month period reflected similar challenges, with the company posting a loss of Rs 2,032.46 millions compared to a profit of Rs 3,114.68 millions in the corresponding period of the previous year.

Consolidated Financial Results

The consolidated financial performance for Q3FY26 demonstrated the broader impact across the group:

On a consolidated basis, the company reported a loss of Rs 2,337.17 millions for Q3FY26, significantly higher than the loss of Rs 265.47 millions in the corresponding quarter of the previous year.

Corporate Restructuring Impact

The financial results reflect the impact of a major corporate restructuring. The National Company Law Appellate Tribunal approved the scheme of amalgamation of Nam Estates Private Limited and Embassy One Commercial Property Developments Private Limited with Embassy Developments Limited on January 7, 2025, with the scheme becoming effective on January 24, 2025.

This transaction was treated as a reverse acquisition for financial reporting purposes, with Nam Estates as the accounting acquirer. The company allotted 609,105,999 equity shares of Rs 2 each to existing shareholders of Nam Estates and changed its name from Equinox India Developments Limited to Embassy Developments Limited.

Share Capital and Warrant Activities

During Q3FY26, the company received Rs 1,551.76 millions as share warrant money, with corresponding shares being allotted. However, certain warrant holders holding 47.53 million convertible warrants did not exercise their conversion rights within the prescribed period. Consequently, Rs 1,324.95 millions in upfront warrant subscription money was forfeited and transferred to Capital Reserve.

The paid-up equity share capital stood at Rs 2,780.07 millions as of December 31, 2025, compared to Rs 1,271.74 millions in the corresponding period of the previous year.

Legal Proceedings Update

The company faces ongoing legal proceedings related to a Corporate Insolvency Resolution Process initiated by the National Company Law Tribunal on December 9, 2025. However, the NCLAT stayed this process on December 11, 2025, pending appeal adjudication. The matter is scheduled for hearing on February 19, 2026. Management expects no material impact on the company's operations based on legal advice.

Regulatory Compliance

The results were submitted under Regulation 33 of the SEBI LODR Regulations, with the Board meeting commencing at 3:15 P.M. and concluding at 4:53 P.M. on February 09, 2026. The trading window for dealing in the company's securities remains closed until February 11, 2026, in compliance with insider trading regulations.